News for Boston Scientific Corporation (BSX)

Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Boston Scientific (BSX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Boston Scientific (BSX) closed at $104.71 in the latest trading session, marking a +1.06% move from the prior day.

The average brokerage recommendation (ABR) for Boston Scientific (BSX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Boston Scientific Corporation (NYSE:BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ETCompany ParticipantsDan Brennan - Chief...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Boston Scientific (BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment.

PR NewswireMARLBOROUGH, Mass., March 3, 2025 Acquisition to expand Interventional Cardiology Therapies offerings with ultrasound-based renal denervation th

PDF Version LYON, France, March 3, 2025 -- EDAP TMS SA ( EDAP) (”œthe Company” or ”œEDAP”), the global leader in robotic energy-based therapies, today an

The Goldman Sachs, The Progressive, Boston Scientific and Cooper-Standard are included in this Analyst Blog.

PROCEPT BioRobotics Corp faces significant net losses with a history of financial challenges.Revenue primarily hinges on the success of the AquaBeam Robotic Sy

Boston Scientific (BSX) closed the most recent trading day at $100.80, moving -0.75% from the previous trading session.

Boston Scientific Corporation (BSX), a global leader in medical device technology, has announced the successful pricing and completion of a significant financ

Here is how Boston Scientific (BSX) and Abivax SA Sponsored ADR (ABVX) have performed compared to their sector so far this year.

PR NewswireMARLBOROUGH, Mass., Feb. 21, 2025 MARLBOROUGH, Mass., Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) to

OTTAWA — Liberal leadership candidate Frank Baylis says Prime Minister Justin Trudeau and Canada’s premiers have been approaching President Donald Trump’s trade thr…

Boston Scientific begins 2025 on a solid note, expecting organic revenue growth of 14% to 16% in the first quarter.

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.

We recently compiled a list of the 10 Best Momentum Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against...